These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11129108)

  • 21. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hereditary cerebellar ataxia with Ganoderma capense. Report of 4 cases.
    Wang ZY; Fu HT
    J Tradit Chin Med; 1981 Sep; 1(1):47-50. PubMed ID: 6926690
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 24. Buspirone in social phobia.
    Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic trial in a family with late cerebellar atrophy].
    Gracia Naya M; Pina Latorre MA
    Neurologia; 1991 May; 6(5):188-9. PubMed ID: 1908256
    [No Abstract]   [Full Text] [Related]  

  • 26. [Buspirone: a new non-benzodiazepine anxiolytic drug].
    Honorato J; Catalán M
    Rev Clin Esp; 1990 Apr; 186(6):286-91. PubMed ID: 2203117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of cerebellar ataxias: A three-year prospective longitudinal assessment.
    Lee YC; Liao YC; Wang PS; Lee IH; Lin KP; Soong BW
    Mov Disord; 2011 Sep; 26(11):2081-7. PubMed ID: 21626567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
    Robinson D; Napoliello MJ; Schenk J
    Clin Ther; 1988; 10(6):740-6. PubMed ID: 3219687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
    Zeldowicz LR; Hubermann J
    Can Med Assoc J; 1973 Oct; 109(7):588-93. PubMed ID: 4582563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa.
    Timberlake WH; Vance MA
    Ann Neurol; 1978 Feb; 3(2):119-28. PubMed ID: 350129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amantadine and rimantadine against influenza A].
    Bruu AL; Orstavik I
    Tidsskr Nor Laegeforen; 1992 Jun; 112(16):2102-4. PubMed ID: 1523633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 33. Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study.
    da Silva-Júnior FP; Braga-Neto P; Sueli Monte F; de Bruin VM
    Parkinsonism Relat Disord; 2005 Nov; 11(7):449-52. PubMed ID: 16154788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF
    N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of Parkinson's disease with amantadine].
    Sigwald J; Raymondeaud C; Grégoire J
    Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
    [No Abstract]   [Full Text] [Related]  

  • 36. [Amantadine for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1101-2. PubMed ID: 5450047
    [No Abstract]   [Full Text] [Related]  

  • 37. An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery.
    Fava M; Targum SD; Nierenberg AA; Bleicher LS; Carter TA; Wedel PC; Hen R; Gage FH; Barlow C
    J Psychiatr Res; 2012 Dec; 46(12):1553-63. PubMed ID: 22998742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physostigmine in treatment of cerebellar ataxia].
    Aschoff JC; Kailer NA; Walter K
    Nervenarzt; 1996 Apr; 67(4):311-8. PubMed ID: 8684510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of amantadine sulfate as a infusion solution in the treatment of parkinsonian syndrome].
    Muschard F; Völler GW
    Med Welt; 1973 Feb; 24(5):183-4. PubMed ID: 4617092
    [No Abstract]   [Full Text] [Related]  

  • 40. Trial of amantadine in Parkinson's disease.
    Campbell AM; Williams MJ
    Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.